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Collecting information on consanguinity is one of the core
concepts of documenting a family’s genetic history. When
it is present, suspicion increases for autosomal-recessive
disorders because of increased allele sharing. Researchers
from Ambry Genetics recently assessed whether this the-
ory bears out. They combed through their first 500 exome
samples to identify cases of known consanguinity and
then compared the results in these consanguineous cases
to the results from the rest of the samples. The diagnostic
rate from the exomes was similar in the consanguineous
group, but unexpectedly, nearly 40% of the diagnostic
findings in the consanguineous group did not follow an
autosomal-recessive pattern of inheritance. In fact, four
of the five diagnostic variants that were not located in
autosomal-recessive genes arose de novo in the proband.
Without genetic testing, recurrence risks of 25% would
be quoted for a consanguineous family with a child
affected by a phenotype of unknown etiology. This result
suggests that a number of these families have amuch lower
risk of recurrence because the inheritance pattern is not
what we expect.
Powis et al. (2015). J. Hum. Genet. Published online October
22, 2015. http://dx.doi.org/10.1038/jhg.2015.125.Large Data for Diabetes
In the many genome-wide association studies for type 2
diabetes, one diabetic individual is like any other, and
these affected individuals are grouped together in a case
group whose genetic variation is compared to that of con-
trol individuals. This is contrary to our understanding that
type 2 diabetes is a complex trait whose genetic contribu-
tions can vary between affected individuals. To better
represent this heterogeneity, Li et al. mined electronic
medical records to find clinically similar individuals with
type 2 diabetes, an exercise that revealed three subgroups.
Genetic contributions to each subgroup were then uncov-
ered via genetic association analysis, revealing many genes
uniquely associated with a single subtype of disease. This
type of study can help us to understand themultiple routes
to get to the same endpoint—type 2 diabetes—and as a
result give us multiple points at which we can try to
intervene.
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In another data-mining experiment, Akawi et al.
analyzed exome sequence and phenotype data from a
sample of more than 4,000 families affected by a devel-
opmental disorder. Although finding the gene containing
the causative mutation in a heterogeneous dataset like
this might seem like finding a needle in a haystack, the
researchers came up with a way to combine information
in the sample to build statistical evidence for candidate
genes. After removing approximately 1,000 families
who appeared to be explained by de novo mutations in
the affected individuals, the authors filtered the geno-
types to identify probands with two rare variants in the
same gene and then looked for probands from other fam-
ilies with variants in the same gene. With the Exome
Aggregation Consortium data as a background, they
calculated the likelihood of identifying unrelated families
with similar genotypes in the general population and
also estimated the probability of phenotypic similarity
between these probands through analysis of Human
Phenotype Ontology (HPO) terms that were recorded
for each family. This multi-pronged analysis pinpointed
four newly disease-related genes, including two cilia
genes, in the sample.
Akawi et al. (2015). Nat. Genet. 47, 1363–1369.Sensitive Genes
Although autism was originally theorized to be a com-
plex trait resulting from unfavorable combinations of
common risk variation in multiple genes, accumulating
evidence suggests that rare de novo variation could be
the cause in a significant number of cases. If this is
true, strong negative selection would be exerted on the
causative variants, and these autism-associated genes
would tend to have lower frequencies of disruptive vari-
ation. Iossifov et al. used data from the Simons Simplex
Collection and NHLBI Exome Sequencing Project Exome
Variant Server to test this theory, and they confirmed
that this is the case. Some of the damaging variants are
transmitted, but this transmission is biased and tends
to be passed from mothers to affected children who
have a low IQ.
Iossifov et al. (2015). Proc. Natl. Acad. Sci. USA 112, E5600–
E5607.ta, GA 30322, USA
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MicroRNAs Serve as Treatment Targets for
Dyslipidemia
Among the many results from genome-wide association
studies (GWASs), a significant number of associations
occur outside of protein-coding genes. What if proteins
are not the key to these associations? Wagschal et al.
took a systematic approach to look for microRNAs
that might be at the heart of the association. Using774 The American Journal of Human Genetics 97, 773–774, DecembGWAS data on plasma lipid levels, they discovered
four microRNAs that neighbor SNPs associated with
the phenotype and are also predicted to target mRNAs
involved in metabolic control. They uncovered miRNAs
that regulate key steps in cholesterol trafficking and
used this newfound knowledge to manipulate choles-
terol and triglyceride levels in a mouse model of
dyslipidemia.
Wagschal et al. (2015). Nat. Med. 21, 1290–1297.This Month in Our Sister JournalsMaster Regulators of Breast Cancer
Even when they affect the same tissue, cancers are het-
erogeneous between people, and breast cancer is
certainly no exception. Li et al. wondered whether there
might be key master regulator genes that modulate un-
derlying pathways involved in breast cancer develop-
ment. If so, they could use the genes to stratify tumors
into more homogenous groups. Using gene-expression
data from The Cancer Genome Atlas, the authors defined
a set of 16 such genes that divide tumors into four clus-
ters representing the four major subtypes of breast tu-mors, and they confirmed these clusters in two addi-
tional breast cancer cohorts. The master regulators
encode transcription factors and can be divided into
two groups that have subtype-specific gene-expression
patterns. Surprisingly, the two groups of regulators affect
cancer drivers and related genes in opposite directions.
Many of the genes on the PAM50 panel, a gene-expres-
sion-based test for characterizing breast tumors, are pre-
dicted targets of the 16 transcription-factor-encoding
genes.
Li et al. (2015). Genetics. Published online October 28, 2015.
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